Effects of commercial air travel on patients with pulmonary hypertension

Chest

Volumn 142, Issue 4, 2012, Pages 885-892

  Roubinian, Nareg ^a   Elliott, C Gregory ^c,d   Barnett, Christopher F ^a   Blanc, Paul D ^a   Chen, Joan ^a   De Marco, Teresa ^a   Chen, Hubert ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTITUDE; ARTICLE; ATMOSPHERIC PRESSURE; AVIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART RATE; HUMAN; HYPOXEMIA; INCIDENCE; MALE; MOBILIZATION; OBSERVATIONAL STUDY; OXYGEN DESATURATION; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEA LEVEL; SYMPTOM;

EID: 84867114733     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2016     Document Type: Article

References (16)

1. U.S. Department of Transportation, Research and Innovative Technology Administration, Bureau of Transportation Statistics. Transtats: passengers: all carriers-all airports. Research and Innovative Technology Administration, Bureau of Transportation Statistics website. http://www.transtats.bts.gov/Data- Elements.aspx?Data=1. Accessed July 27, 2010.
2. Dillard TA, Rosenberg AP, Berg BW. Hypoxemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest. 1993;103(2):422-425. (Pubitemid 23070738)
3. Luks AM. Can patients with pulmonary hypertension travel to high altitude? High Alt Med Biol. 2009;10(3):215-219.
4. British Thoracic Society Standards of Care Committee. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2002;57(4):289-304.
5. Moyle J. Medical guidelines for airline travel. Aviat Space Environ Med. 2003;74(9):1009.
6. Seccombe LM, Kelly PT, Wong CK, Rogers PG, Lim S, Peters MJ. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax. 2004;59(11):966-970. (Pubitemid 39490782)
7. Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984;130(6):980-986. (Pubitemid 15191905)
8. Berg BW, Dillard TA, Derderian SS, Rajagopal KR. Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease. Am J Med. 1993;94(4):407-412. (Pubitemid 23106628)
9. Berg BW, Dillard TA, Rajagopal KR, Mehm WJ. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest. 1992;101(3):638-641.
10. Dillard TA, Berg BW, Rajagopal KR, Dooley JW, Mehm WJ. Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1989;111(5):362-367. (Pubitemid 19231289)
11. Dillard TA, Moores LK, Bilello KL, Phillips YY. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest. 1995;107(2):352-357.
12. Naughton MT, Rochford PD, Pretto JJ, Pierce RJ, Cain NF, Irving LB. Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation? Am J Respir Crit Care Med. 1995;152(6 Pt 1):1956-1960.
13. Akerø A, Edvardsen A, Christensen CC, Owe JO, Ryg M, Skjønsberg OH. COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen. Chest. 2011;140(1):84-90.
14. Kelly PT, Swanney MP, Seccombe LM, Frampton C, Peters MJ, Beckert L. Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD. Chest. 2008;133(4):920-926. (Pubitemid 351536867)
15. Akerø A, Christensen CC, Edvardsen A, Skjønsberg OH. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J. 2005;25(4):725-730. (Pubitemid 40528769)
16. Christensen CC, Ryg M, Refvem OK, Skjønsberg OH. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. Eur Respir J. 2000;15(4):635-639. (Pubitemid 30196288)